Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
29.4M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
902K
-
Shares change
-
+721K
-
Total reported value, excl. options
-
$1.5M
-
Value change
-
+$1.19M
-
Number of buys
-
13
-
Number of sells
-
-5
-
Price
-
$1.66
Significant Holders of SeaStar Medical Holding Corp - Common Stock, $0.0001 par value (ICU) as of Q1 2025
27 filings reported holding ICU - SeaStar Medical Holding Corp - Common Stock, $0.0001 par value as of Q1 2025.
SeaStar Medical Holding Corp - Common Stock, $0.0001 par value (ICU) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 902K shares
of 29.4M outstanding shares and own 3.07% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (613K shares), GEODE CAPITAL MANAGEMENT, LLC (74.6K shares), VANGUARD GROUP INC (57.5K shares), Tyche Wealth Partners LLC (37.7K shares), RAYMOND JAMES FINANCIAL INC (37.3K shares), NORTHERN TRUST CORP (12.8K shares), XTX Topco Ltd (12.3K shares), GOLDMAN SACHS GROUP INC (10.2K shares), Trinity Financial Advisors LLC (10K shares), and GREAT VALLEY ADVISOR GROUP, INC. (10K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.